HOME >> BIOLOGY >> NEWS
ORNL wins four R&D 100 awards, pushing total to 116

OAK RIDGE, Tenn., July 2, 2003 -- Researchers at the Department of Energy's Oak Ridge National Laboratory have won four R&D awards from R&D Magazine, which since 1963 has given the awards for the 100 most significant innovations of the year.

"All of us at ORNL are extremely proud of our staff for winning these awards," said ORNL Director Bill Madia. "The award is among the most coveted in the world of scientific research, and winning it brings prestige to both the researcher and the laboratory."

ORNL's total of 116 awards is second only to General Electric. The following inventions received honors:

RAMiTS: Raman Integrated Tunable Sensor, developed and submitted by Tuan Vo-Dinh, Joel Mobley, Brain Cullum and David Stokes of the Life Sciences Division, and Alan Wintenberg and Steven Frank of the Engineering Science and Technology Division. Robert Maples of RIS of Knoxville is a co-developer.

RAMiTS is a compact, "point-and-shoot," fully integrated, battery-operated Raman monitor and is based on solid-state acoustooptic tunable filter technology. Outside the laboratory, this device can perform qualitative analysis of chemical and biological samples in seconds. RAMiTS can identify hundreds of substances, including toxic chemicals, by-products from explosives, biomedical markers, pharmaceuticals and illicit drugs. RAMiTS also could help revolutionize sensing applications such as environmental monitoring, medical diagnostics and homeland security, researchers said.

MicroTrapMS, developed and submitted jointly by Michael Ramsey, William Whitten and Peter Reilly of the Chemical Sciences Division; Oleg Kornienko, postdoctoral ORNL fellow; and Protasis Corp. of Marlboro, Mass.

MicroTrapMS is a highly miniaturized ion trap mass spectrometer that is based on ORNL patented technology. The product can be used for applications from on-line screening for toxins in municipal watersheds to detecting hazardous substances at airport chec
'"/>

Contact: Ron Walli
wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
2-Jul-2003


Page: 1 2 3

Related biology news :

1. Scientists receive awards, give lectures at the ASBMB/IUBMB meeting
2. ORNL adds three R&D 100s to DOE lab-leading total
3. NIH consensus panel confirms effectiveness of total knee replacement
4. Sleep debts accrue when nightly sleep totals six hours or fewer
5. AFAR announces 189 new grants for aging research totalling $10 million
6. Whitaker makes largest individual grants ever totaling more than $30 million

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ORNL wins four awards pushing total

(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
(Date:7/30/2015)... CITY, Kan. , July 30, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the ... for companion animals, today announced that its strategic ... from a dose confirmation study of AT-016, an ... Aratana for the treatment of osteoarthritis pain in ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... As part of its 2015 growth plan ... and technical service business units, Whitehouse Laboratories is pleased to announce that ... adjacent to the Container Center of Excellence and will be strictly dedicated to basic USP ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
Cached News: